MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Solution

国药准字H20213134

February 24, 2021

Drug Information

盐酸左西替利嗪口服溶液

口服溶液剂

0.05%(150ml:75mg)

化学药品

February 24, 2021

Company Information

Applicant Company

厦门市海沧区后祥路71号5号楼第5层之一

Manufacturing Company

福州市晋安区鼓山镇中下278号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服溶液 - NMPA 批准文号 | MedPath